Are you a new member? Sign up now
Login area
| Sign up
close
NOVOSEVEN RT - 1mg (50KIU) - 1
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B02BD08 | BioTech | Eptacog alfa (activated) recombinant - 1mg | 5540 | 218019/09 | NOVOSEVEN RT | 1mg (50KIU) | 1 | Injectable powder for solution+diluent | IV | Mersaco | Novo Nordisk AS | Denmark | 54,851,623 L.L | 10.71 | E1 | Novo Nordisk AS | Denmark | 12/12/20 | 0 |
Drugs With Same Ingredients
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B02BD08 | BioTech | Eptacog alfa - 1mg | 10083 | 139519/1 | ARYOSEVEN RT | 1mg | 1 | Injectable powder for solution+diluent | IV | Lebiran SARL | Aryogen Pharmed | Iran | 16,902,713 L.L | 19.35 | D | Aryogen Pharmed | Iran | 12/12/20 | 0 |
| B02BD08 | BioTech | Eptacog alfa - 1mg | 10083/388 | 139519/1 | ARYOSEVEN RT | 1mg | 1 | Injectable powder for solution+diluent | IV | Lebiran SARL | Aryogen Pharmed | Iran | L.L | 19.35 | D | Aryogen Pharmed | Iran | 05/02/20 | |
| B02BD08 | BioTech | Eptacog alfa (activated) recombinant - 1mg | 5540/388 | 218019/09 | NOVOSEVEN RT | 1mg (50KIU) | 1 | Injectable powder for solution+diluent | IV | Mersaco | Novo Nordisk AS | Denmark | L.L | 10.71 | E1 | Novo Nordisk AS | Denmark | 05/02/20 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024